New year – new plans

The year is coming to an end by leaps and bounds and the same applies to my first two months at Flemingsberg Science. My expectations of the new assignment, ongoing operations, networks and partners have been easily met.

Campus Flemingsberg is unique and there is the power and will to develop the campus area even more. Here, of course, Flemingsberg Science will contribute through the assignment to develop knowledge-intensive activities in Flemingsberg.

When we enter 2022, we will do so with a new strategic focus for the foundation’s work. The Board has formulated three strategic goals for the period 2022-2025. The goals are clear: Flemingsberg will be the first choice for establishments in southern Stockholm. Flemingsberg will offer an internationally competitive innovation environment. In addition, Flemingsberg will be developed into a test bed for urban societal challenges.

We are now looking ahead and will in January present plans that will take us to set goals.

We at Flemingsberg Science wish you a Merry Christmas and a Happy New Year!

Johnny Högberg
CEO, Flemingsberg Science

Stockholm region’s only GameTech hub is being built in Flemingsberg

In September this year, Press Start took the next step in developing the Stockholm region’s GameTech ecosystem. Since then, the community has continued to grow, more studios have joined, and work on the next major initiative has gained momentum. So, what has happened so far, and what comes next?

CSIB: New interdisciplinary center brings research together to tackle future infectious threats

Center for Systems Infection Biology (CSIB) was recently inaugurated at Campus Flemingsberg. The new interdisciplinary initiative brings together research, advanced infrastructure and expertise to deepen the understanding of infectious diseases and accelerate the path from research to clinical application. We met with Director Ujjwal Neogi and Co-director Iva Filipovic to talk about the center’s goals, its strong focus on collaboration, and its ambition to contribute to pandemic preparedness.

Vecura – 30 Years Dedicated to the Medicine of the Future

In Flemingsberg, pioneers have helped shape the medicine of the future since 1996. This year, the manufacturing unit Vecura celebrates 30 years of supporting the development of cell and gene therapies – advanced therapies that enable more personalized treatments. We spoke with Pontus Blomberg, strategic advisor and former Director of Operations, who has helped build one of Sweden’s leading laboratories in the field.

Do you want to know more?
Subscribe to our newsletter.

Do you want to know more?
Subscribe to our newsletter.

CF_logo_neg
2021-12-20T14:45:47+01:00
Go to Top